# Standardized clinical assessment and management plans revisited: lessons learned from a decade of implementation

## TL;DR

SCAMPs are flexible care pathways designed to reduce unnecessary variation in medical care, and this paper reviews their development and impact over the past decade.

## Contribution

This paper provides a comprehensive synthesis of SCAMPs' implementation experiences and lessons learned over ten years.

## Key findings

- SCAMPs have been widely deployed across diverse conditions and institutions.
- They show potential to reduce practice variation and improve resource use.
- Implementation challenges include inconsistent study designs and limited evaluation of equity and harms.

## Abstract

Originally introduced in Health Affairs in 2013, Standardized Clinical Assessment and Management Plans (SCAMPs) are clinician-developed, modifiable care pathways designed to reduce unwarranted variation and optimize resource use while preserving professional judgment. Unlike traditional clinical practice guidelines that prescribe “best” practice, SCAMPs begin with consensus-based “sound” practice and emphasize iterative learning from real-world deviations and outcomes. Initially developed for conditions with limited evidence, SCAMPs have since expanded across a wide range of diagnoses and care settings.

We conducted a structured historical review of more than 40 peer-reviewed publications describing SCAMPs development, implementation, evaluation, and iterative refinement. The review synthesizes reported experiences across clinical domains, settings, and study designs, and is intended as a descriptive, perspective-oriented assessment rather than a formal systematic review.

Published SCAMPs reports describe broad deployment across diverse conditions and institutions, with recurrent findings of reduced practice variation, changes in resource utilization, iterative pathway refinement, and high reported adherence among participating clinicians. The literature also reflects important limitations, including heterogeneity of study designs, limited evaluation of harms, equity, patient-reported outcomes, and implementation burden, and likely underrepresentation of unsuccessful implementations. Early reliance on paper-based workflows constrained scalability and consistency of use.

This perspective synthesizes the published SCAMPs experience, highlighting reported benefits alongside implementation conditions, risks, and limitations. SCAMPs are best understood as a clinician-led methodology whose value is conditional on governance, analytic capacity, patient safety oversight, and attention to equity. Emerging informatics standards and artificial intelligence tools may enhance scalability and learning, but require careful governance to avoid amplifying bias or harm.